Dr. Evan L. Fogel, MD

Dr. Fogel practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Fogel's NPI, 1164486684, was assigned on April 13, 2006. Dr. Fogel holds Indiana license 01045682.

Dr. Fogel's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Fogel's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Fogel is also affiliated with IU Health North Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Fogel to 2 more hospitals, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fogel practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Fogel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Fogel is licensed in Indiana.

CMS data shows 546 Medicare services from Dr. Fogel across 12 procedure codes in 2024, for 152 Medicare patients. Medicare paid $64,406 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 152 Medicare patients who saw Dr. Fogel in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fogel's median patient age at 58, with 57% women.

In 2024, Dr. Fogel wrote 19 Medicare Part D claims. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $47,761 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

Dr. Fogel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 251 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Fogel, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 96 papers to Dr. Fogel, published from 2010 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis and Pancreatitis, Chronic. Dr. Fogel has published most often in Gastrointest Endosc. Dr. Fogel's most frequent co-authors are Glen A. Lehman, MD, James L. Watkins, MD and Lee McHenry, MD.

Dmand AI links Dr. Fogel to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Pancreatitis, Pancreas Divisum and Pancreatitis, Chronic. Open Payments lists research payments to Dr. Fogel that name 1 trial.

CMS Open Payments shows 38 general payments to Dr. Fogel from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $947. It also lists 1 research payment totaling $6,300 in 2019, naming 1 clinical trial.